e-learning
resources
Courses
2019
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Initial anticoagulant treatment and home treatment of PE
C. Becattini
Source:
ERS Course 2019 - Masterclass in pulmonary embolism
Number:
3
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. Becattini. Initial anticoagulant treatment and home treatment of PE. ERS Course 2019 - Masterclass in pulmonary embolism
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Prolonged anticoagulation in VTE with direct oral anticoagulants: towards an individual analysis of net clinical benefit?
Source: Eur Respir J 2016; 48: 1268-1270
Year: 2016
Management of recurrent PE in patients on anticoagulant therapy
Source: Virtual Congress 2021 – Pulmonary embolism: special situations
Year: 2021
Long-term treatment of PE
Source: ERS Course 2019 - Masterclass in pulmonary embolism
Year: 2019
Management of anticoagulant and antiplatelet therapy in patients undergoing interventional pulmonary procedures
Source: Eur Respir Rev, 26 (145) 170020; 10.1183/16000617.0020-2017
Year: 2017
Outpatient treatment and early discharge of symptomatic pulmonary embolism: a systematic review
Source: Eur Respir J 2009; 33: 1148-1155
Year: 2009
Outcome of drug resistant TB in hospital settings-a comparision of individualized treatment based on past history of anti-TB drugs with culture sensitivity guided treatment
Source: Eur Respir J 2006; 28: Suppl. 50, 589s
Year: 2006
Management of bleeding during anticoagulant therapy
Source: International Congress 2019 – Update on anticoagulant therapy: controversy and progress
Year: 2019
Features of intravenous anti TB therapy in patients with first diagnosed pulmonary TB in the intensive phase of treatment
Source: International Congress 2017 – MDRTB: detection and management
Year: 2017
Faster clinical improvement and earlier discharge from hospital in CAP patients under sequential moxifloxacin treatment compared to standard therapy
Source: Eur Respir J 2004; 24: Suppl. 48, 188s
Year: 2004
Add on therapy of pure theophylline sollution with systemic corticosteroid is more effective for the treatment of asthma attack
Source: Eur Respir J 2004; 24: Suppl. 48, 344s
Year: 2004
Clinical efficacy of oral sildenafil therapy in the treatment of pulmonary hypertension
Source: Eur Respir J 2007; 30: Suppl. 51, 347s
Year: 2007
Long-term effectiveness of surgery treatment of TB patients
Source: Virtual Congress 2020 – Tuberculosis and adverse events in different populations
Year: 2020
Duration of anticoagulant therapy: a change in the paradigm
Source: International Congress 2019 – Update on anticoagulant therapy: controversy and progress
Year: 2019
Anticoagulant treatment of venous thromboembolism: established and new oral agents, remaining questions
Source: International Congress 2014 – Current controversies in the management of acute pulmonary embolism
Year: 2014
Rivaroxaban versus standard anticoagulation for the treatment of pulmonary embolism: a real-life study
Source: International Congress 2019 – Pulmonary embolism: from diagnosis to prognosis and treatment
Year: 2019
Prospects for the prevention and treatment of venous thromboembolism
Source: ISSN=1025-448x, ISBN=1-904097-31-6, page=155
Year: 2004
Treatment of CTEPH and anticoagulation of choice
Source: ERS Course 2019 - Masterclass in pulmonary embolism
Year: 2019
Severe asthma and biologic therapies during COVID-19: supporting patients care with home administration of mepolizumab and omalizumab
Source: Virtual Congress 2021 – Asthma clinical trials and real-life studies
Year: 2021
Has the time come to shorten TB treatment and TB preventive therapy?
Source: Virtual Congress 2021 – Respiratory infections
Year: 2021
Treatment of VTE during pregnancy with a once-daily regimen of LMWH
Source: Annual Congress 2007 - Acute and chronic pulmonary embolism
Year: 2007
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept